SCHEMBL9714564

SCHEMBL9714564

CC(C)C(C=O)c1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.50
ESR2 Q92731 9/20 0.50
PDCD1 Q15116 1/20 0.50
CD274 Q9NZQ7 1/20 0.50
CYP2C9 P11712 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
PGR P06401 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
AR P10275 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
CHRM1 P11229 1/20 0.40
ALOX15 P16050 1/20 0.40
DRD1 P21728 1/20 0.40
TBXA2R P21731 1/20 0.40
PTGS1 P23219 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7574632 0.85 ESR1 (0.48) ESR1ESR2PDCD1CD274CYP2C9
SCHEMBL9827431 0.81 ESR1 (0.39) ESR1ESR2PDCD1CD274CYP2C9
SCHEMBL8663245 0.78 FFAR2 (0.47) TDP1LMNATYRHIF1A
SCHEMBL9979942 0.78 CYP1A2 (0.39) CYP1A2CYP2C19TYRALDH1A1SMN1; SMN2
SCHEMBL12361451 0.78 ESR1 (0.50) ESR1ESR2PDCD1CD274CYP2C9
SCHEMBL13827629 0.78 ESR1 (0.50) ESR1ESR2PDCD1CD274CYP2C9
SCHEMBL351626 0.77 ESR1 (0.54) ESR1ESR2PDCD1CD274CYP2C9
SCHEMBL3503957 0.77 CYP2D6 (0.41) LMNACYP2D6ALDH1A1KDM4EHIF1A
SCHEMBL13827770 0.77 ESR1 (0.48) ESR1ESR2PDCD1CD274CYP2C9
SCHEMBL14220303 0.77 ESR1 (0.48) ESR1ESR2PDCD1CD274CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166210-A QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1992-11-24 US disclosed
US-5028615-A Treatment of hypersensitivity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-07-02 US disclosed
US-4920133-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed